New kidney cancer model highlights molecular targets and genomic events that drive metastasis

FHS
June 27, 2023
1:01 am

Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.

Tyra’s TYRA-300 gains FDA rare paediatric disease status

Share this article Tyra Biosciences is preparing to file an IND application to the regulator in the second half of 2024. Credit: Gorodenkoff / Shutterstock.com.

February 2, 2024

With yearslong reorganization behind it, Novartis increases its sales guidance

Novartis’ reorganization is paying off, CEO Vas Narasimhan told investors at an event Thursday in London. The company raised its sales guidance through 2028 and

November 22, 2024

Epigenetic formatting of satiety gene may increase risk of obesity in women

What determines whether we become overweight? Aside from lifestyle, predisposition plays a role, but genes cannot fully explain the inherited propensity to accumulate excess weight.

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.